Results 251 to 260 of about 1,988,593 (307)
Chronic Myeloid Leukemia: Historical Perspective, Pathophysiology, and Treatment Advances.
Tungjitviboonkun S, Daran L, Unsuwan S.
europepmc +1 more source
Treatment patterns and outcomes of tyrosine kinase inhibitors in chronic myeloid leukemia: a single center study from Oman. [PDF]
Al-Rawahi N +5 more
europepmc +1 more source
Immunologic desensitization to nilotinib in a patient with chronic myeloid leukemia with hypersensitivity and complex comorbidities. [PDF]
Widagdo TSC +4 more
europepmc +1 more source
Simulation of Imatinib Pharmacokinetics in pregnant women with chronic myeloid leukemia in the third trimester. [PDF]
Mian P +8 more
europepmc +1 more source
Prevalence and Prognostic Impact of ASXL1 Somatic Mutation in Patients with Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis. [PDF]
Ahmad R +13 more
europepmc +1 more source
Monitoring treatment and survival in chronic myeloid leukemia
The Italian Group for Bone Marrow transplantation +3 more
core
Some of the next articles are maybe not open access.
Related searches:
Related searches:
New England Journal of Medicine, 1999
Over the past twenty years, clinical and laboratory studies have led to important new insights into the biology of chronic myeloid leukemia. Basic science has defined the molecular pathogenesis of chronic myeloid leukemia (CML) as unregulated signal transduction by the Bcr-Abl tyrosine kinase.
Charles Sawyers
exaly +3 more sources
Over the past twenty years, clinical and laboratory studies have led to important new insights into the biology of chronic myeloid leukemia. Basic science has defined the molecular pathogenesis of chronic myeloid leukemia (CML) as unregulated signal transduction by the Bcr-Abl tyrosine kinase.
Charles Sawyers
exaly +3 more sources

